Safety
Abaloparatide
Adverse-event report summary for Abaloparatide, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 439
- Reports flagged serious
- 375
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Dizziness49 reports
- Nausea44 reports
- Headache38 reports
- Palpitations36 reports
- Physical Deconditioning36 reports
- Injection Site Pain29 reports
- Injection Site Haemorrhage28 reports
- Back Pain26 reports
- Blood Pressure Decreased26 reports
- Malaise26 reports
- Injection Site Erythema22 reports
- Fall21 reports
- Feeling Abnormal21 reports
- Pyrexia21 reports
- Blood Pressure Increased18 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.